Neurovirtual USA Inc obtained Food and Drug Administration (FDA) clearance of the Sleepvirtual BW3 EEG and PSG System, the newest FDA-approved innovation from the company.
The BW3 is a complete system that combines full type 1 PSG with epilepsy montage and full EEG, QEEG, VEEG, and LTM in one device. “My vision is to make the BW3 the gold standard inside sleep labs and neurology departments,” said Ed Faria, MBA, CEO of Neurovirtual.
For over 12 years, Neurovirtual has specialized in developing, manufacturing, marketing, and servicing high-technology medical devices used in sleep medicine and neurology. The company was selected for the 2009 and 2011 Best of Business Award.